Monitoring of cellular resistance to cancer chemotherapy: Drug retention and efflux

Methods in Cell Biology

Volumn 64, Issue 64, 2001, Pages 193-209

  Krishan, Awtar ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; CALCIUM CHANNEL BLOCKING AGENT; CHLORPROMAZINE; DAUNORUBICIN; DOXORUBICIN; FLUORESCENT DYE; RHODAMINE 123; VERAPAMIL;

ANIMAL; ARTICLE; CELL CULTURE; CELL MEMBRANE PERMEABILITY; DRUG RESISTANCE; FLOW CYTOMETRY; HUMAN; INSTRUMENTATION; METABOLISM; METHODOLOGY; MOUSE; MULTIDRUG RESISTANCE; STAINING;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; CALCIUM CHANNEL BLOCKERS; CELL MEMBRANE PERMEABILITY; CHLORPROMAZINE; DAUNORUBICIN; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FLOW CYTOMETRY; FLUORESCENT DYES; HUMANS; MICE; RHODAMINE 123; STAINING AND LABELING; TUMOR CELLS, CULTURED; VERAPAMIL;

EID: 35448997856     PISSN: 0091679X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0091-679x(01)64014-7     Document Type: Article

References (52)

1. Alabaster, O., Woods, T., Ortiz-Sanchez, V., and Jahangeer, S. (1989). Influence of microenvironmental pH on adriamycin resistance. Cancer Res. 49, 5638-5643.
2. Ayesh, S., Lyubimov, E., Algour, N., and Stein, W. D. (1996). Reversal of P-glycoprotein is greatly reduced by the presence of plasma but can be monitored by an ex vivo clinical assay. Anti-Cancer Drugs 7, 678-686.
3. Beck, W. T. (1983). Vinca alkaloid-resistant phenotype in cultured human leukemic lymphoblasts. Cancer Treat. Rep. 10, 875-882.
4. Biedler, J. L. (1994). Drug resistance: Genotype versus phenotype. Thirty-second G. H. A. Clowes Memorial Award Lecture. Cancer Res. 54, 666-678.
5. Chan, H. S., Thorner, P. S., Haddad, G., and Ling, V. (1990). Immunohistochemical detection of P-glycoprotein: Prognostic correlation in soft tissue sarcoma of childhood. J. Clin. Oncol. 8, 689-704.
6. Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., and Deeley, R. G. (1992). Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258, 1650-1654.
7. Dalton, W. S., Crowley, J. J., Salmon, S. S., Grogan, T. M., Laufman, L. R., Weiss, G. R., and Bonnet, J. D. (1995). A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma: A Southwest Oncology Group study. Cancer 75, 815-820.
8. Deffie, A. M., Alam, T., Seneviratne, C., Beenken, S. W., Batra, J. K., Shea, T. C., Henner, W. D., and Goldenberg, G. J. (1988). Multifactorial resistance to adriamycin: Relationship of DNA repair, glutathione transferase activity, drug efflux and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia. Cancer Res. 48, 3595-3602.
9. Durand, R. and Olive, P. (1981). Flow cytometric studies of intracellular adriamycin in single cells in vitro. Cancer Res. 41, 3489-3494.
10. Feller, N., Kuiper, C. M., Lankelma, J., Ruhdal, J. K., Scheper, R. J., Pinedo, H. M., and Broxterman, H. J. (1995). Functional detection of MDR1/p170 and MRP/p190-mediated multidrug resistance in tumour cells by flow cytometry. Br. J. Cancer 72, 543-549.
11. Frey, T., Yue, S., and Haugland, R. P. (1995). Dyes providing increased sensitivity in flow-cytometric dye-efflux assays for multidrug resistance. Cytometry 20, 218-227.
12. Ganapathi, R., Grabowski, D., Rouse, W., and Riegler, F. (1981). Differential effect of the calmodulin inhibitor trifluoperazine on cellular accumulation, retention, and cytotoxicity of anthracyclines in doxorubicin (adriamycin)-resistant P388 mouse leukemia cells. Cancer Res. 44, 5056-5061.
13. Gifford, A. J., Kavallaris, M., Madafiglio, J., Matherly, L. H., Stewart, B. W., Haber, M., and Norris, M. D. (1998). P-glycoprotein-mediated methotrexate resistance in CCRF-CEM sublines deficient in methotrexate accumulation due to a point mutation in the reduced folate carrier gene. Int. J. Cancer 78, 176-181.
14. Gottesman, M. M. (1993). How cancer cells evade chemotherapy: Sixteenth Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res. 53, 747-754.
15. Gros, P., Dhir, R., Croop, J., and Talbot, F. (1991). A single amino acid substitution strongly modulates the activity and substrate specificity of the mouse mdr1 and mdr3 drug efflux pumps. Proc. Natl. Acad. Sci. U.S.A. 88, 7289-7293.
16. Haugland, R. P. (1996). "Molecular Probes' Handbook of Fluorescent Probes and Research Chemicals," 6th Ed. Molecular Probes, Eugene, Oregon.
17. Hollo, Z., Homola, L., Davis, C. W., and Sakardi, B. (1994). Calcein accumulation as a fluorometric functional assay of the multidrug transporter. Biochim. Biophys. Acta 1191, 384-388.
18. Izquierdo, M. A., Scheffer, G. L., Flens, M. J., Giaccone, G., Broxterman, H. J., Meijer, C. J. L. M., van der Valk, P., and Scheper, R. J. (1996). Broad distribution of the multidrug resistance-related vault lung protein in normal human tissues and tumors. Am. J. Pathol. 148, 877-887.
19. Jedlitschky, G., Leier, I., Buchholz, U., Barnouin, K., Kurz, G., and Keppler, D. (1996). Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res. 56, 988-994.
20. Juliano, R. L., and Ling, V. (1976). A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta 455, 152-162.
21. Kartner, N., Evernden-Porelle, D., Bradley, G., and Ling, V. (1985). Detection of P-glycoprotein in multidrug resistant cell lines by monoclonal antibodies. Nature 316, 820-823.
22. Krishan, A. (1975). Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J. Cell Biol. 66, 188-193.
23. Krishan, A. (1987). Effect of drug efflux blockers on vital staining of cellular DNA with Hoechst 33342. Cytometry 8, 642-645.
24. Krishan, A. (1995). Heterogeneity of anthracycline retention and response to efflux blockers in human tumors. Cytometry 21, 72-75.
25. Krishan, A., and Bourguignon, L. Y. W. (1984). Cell cycle related phenothiazine effects on adriamycin transport. Cell Biol. Int. Rep. 8, 449-457.
26. Krishan, A., and Ganapathi, R. (1980). Laser flow cytometric studies on intracellular fluorescence of anthracyclines. Cancer Res. 40, 3895-3900.
27. Krishan, A., Raychaudhuri, R., and Flowers, A. (1969). Karyotype studies on human leukemic lymphoblasts in vitro and as serial transplants in neonatal Syrian hamsters. J. Natl. Cancer Inst. 43, 1203-1214, 1969.
28. Krishan, A., Sauerteig, A., and Gordon, K. (1985a). Effect of amphotericin B on adriamycin transport in P388 cells. Cancer Res. 45, 4097-4102.
29. Krishan, A., Sauerteig, A., and Wellham, L. (1985b). Flow cytometric studies on modulation of cellular adriamycin retention by phenothiazines. Cancer Res. 45, 1046-1051.
30. Krishan, A., Sridhar, K. S., Davila, E., Vogel, C., and Sternheim, W. (1987). Patterns of anthracycline retention modulation in human tumor cells. Cytometry 8, 306-314.
31. Krishan, A., Sauerteig, A., and Stein, J. H. (1991). A comparison of three commercially available antibodies for flow cytometric monitoring of P-glycoprotein expression in tumor cells. Cytometry 12, 731-742.
32. Krishan, A., Sauerteig, A., Andritsch, I., and Wellham, L. (1997). Flow cytometric analysis of the multiple drug resistance phenotype. Leukemia 11, 1138-1146.
33. Lehnert, M., de Giuli, R., and Twentyman, P. R. (1996). Sensitive and rapid bioassay for analysis of P-glycoprotein-inhibiting activity of chemosensitizers in patient serum. Clin. Cancer Res. 2, 403-410.
34. Leibovitz, A. L., Stinson, J. C., McCombs, W. B., McCoy, C. E., Mazur, K. C., and Mabry, N. D. (1976). Classification of human colorectal adenocarcinoma cell lines. Cancer Res. 36, 4562-4569.
35. Leonessa, F., Jacobson, M., Boyle, B., Lippman, J., McGarvey, M., and Clarke, R. (1994). Reversal of P-glycoprotein-mediated multidrug resistance by pure anti-oestrogens and novel tamoxifen derivatives. Biochem. Pharmacol. 48, 277-285.
36. Ling, V. (1992). P-glycoprotein and resistance to anticancer drugs. Cancer 69, 2603-2609.
37. Maniar, N., Krishan, A., Israel, M., and Samy, T. S. A. (1988). Anthracycline-induced DNA breaks and resealing in doxorubicin-resistant murine leukemic P388 cells. Biochem. Pharmacol. 37, 1763-1772.
38. Nair, S., Singh, S. V., Samy, T. S., and Krishan, A. (1990). Anthracycline resistance in murine leukemic P388 cells: Role of drug efflux and glutathione related enzymes. Biochem. Pharmacol. 39, 723-728.
39. Pallis, M., and Russell, N. H. (1998). Functional multidrug resistance in acute myeloblastic leukemia: A standardized flow cytometric assay for intracellular daunorubicin accumulation. Br. J. Haematol. 100, 194-197.
40. Ramachandran, C., Mead, D., Wellham, L., Sauerteig, A., and Krishan, A. (1995). Expression of drug resistance associated mdr-1, GSTπ, and topoisomerase II genes during cell cycle. Biochem. Pharmacol. 49, 545-552.
41. Ramachandran, C., Kunikane, H., You, W., and Krishan, A. (1998). Phorbol ester induced P-glycoprotein phosphorylation and functionality in HTB-123 human breast cancer cell line. Biochem. Pharmacol. 56, 709-718.
42. Ross, D. D., Gao, Y., Yang, W., Leszyk, J., Shively, J., and Doyle, L. A. (1997). The 95-kilodalton membrane glycoprotein overexpressed in novel multidrug-resistant breast cancer cells is NCA, the nonspecific cross-reacting antigen of carcinoembryonic antigen. Cancer Res. 57, 5460-5464.
43. Shalinsky, D. R., Andreeff, M., and Howell, S. B. (1990). Modulation of drug sensitivity by dipyridamole in multidrug resistant tumor cells in vitro. Cancer Res. 50, 7537-7543.
44. Shen, D., Pastan, I., and Gottesman, M. M. (1998). Cross-resistance to methotrexate and metals in human cisplatin-resistant cell lines results from a pleiotropic defect in accumulation of these compounds associated with reduced plasma membrane binding proteins. Cancer Res. 58, 268-275.
45. Sikic, B. I., Fisher, G. A., Lum, B. L., Halsey, J., Beketic-Oreskovic, L., and Chen, G. (1997). Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein. Cancer Chemother. Pharmacol. 40(Suppl), S13-S19.
46. Slater, L. M., Sweet, P., Stupecky, M., Wetzel, M. W., and Gupta, S. (1986). Cyclosporin A corrects daunorubicin resistance in Ehrlich ascites carcinoma. Br. J. Cancer 54, 235-238.
47. Stein, W. D. (1997). Kinetics of the multidrug transporter (P-glycoprotein) and its reversal. Physiol. Rev. 77, 545-590.
48. Thomas, G. A., Barrand, M. A., Stewart, S., Rabbitts, P. H., Williams, E. D., and Twentyman, P. R. (1994). Expression of the multidrug resistance-associated protein (MRP) gene in human lung tumours and normal tissue as determined by in situ hybridization. Eur. J. Cancer 30A, 1705-1709.
49. Trump, D. L., Smith, D. C., Ellis, P. G., Rogers, M. P., Schold, S. C., Winer, E. P., Panella, T. J., Jordan, V. C., and Fine, R. L. (1992). High dose oral tamoxifen, a potential multidrug-resistance-reversal agent: Phase I trial in combination with vinblastine. J. Natl. Cancer Inst. 84, 1811-1816.
50. Tsuruo, T., Iida, H., Tsukagoshi, S., and Sakurai, Y. (1981). Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytoxicity of vincristine and vinblastine by verapamil. Cancer Res. 41, 1967-1972.
51. Wielinga, P. R., Heijn, M., Broxterman, H. J., and Lankelma, J. (1997). P-Glycoprotein-independent decrease in drug accumulation by phorbol ester treatment of tumor cells. Biochem. Pharmacol. 54, 791-799.
52. Xie, X. Y., Robb, D., Chow, S., and Hedley, D. W. (1995). Disconcordant P-glycoprotein antigen expression and transport function in acute myeloid leukemia. Leukemia 9, 1882-1887.